SABIO HOLDINGS INC (SBIO.CA) Fundamental Analysis & Valuation

TSX-V:SBIO • CA78570Q1081

Current stock price

0.23 CAD
+0.01 (+2.22%)
Last:

This SBIO.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. SBIO.CA Profitability Analysis

1.1 Basic Checks

  • In the past year SBIO has reported negative net income.
  • In the past year SBIO had a positive cash flow from operations.
  • In the past 5 years SBIO always reported negative net income.
  • In multiple years SBIO reported negative operating cash flow during the last 5 years.
SBIO.CA Yearly Net Income VS EBIT VS OCF VS FCFSBIO.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 2M -2M -4M

1.2 Ratios

  • SBIO has a Return On Assets of -37.62%. This is in the lower half of the industry: SBIO underperforms 72.73% of its industry peers.
Industry RankSector Rank
ROA -37.62%
ROE N/A
ROIC N/A
ROA(3y)-9.32%
ROA(5y)-8.06%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SBIO.CA Yearly ROA, ROE, ROICSBIO.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 100 -100 200 300 400

1.3 Margins

  • In the last couple of years the Operating Margin of SBIO has grown nicely.
  • SBIO has a Gross Margin of 60.91%. This is amongst the best in the industry. SBIO outperforms 100.00% of its industry peers.
  • In the last couple of years the Gross Margin of SBIO has remained more or less at the same level.
  • The Profit Margin and Operating Margin are not available for SBIO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 60.91%
OM growth 3Y45.05%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.9%
GM growth 5YN/A
SBIO.CA Yearly Profit, Operating, Gross MarginsSBIO.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. SBIO.CA Health Analysis

2.1 Basic Checks

  • SBIO does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, SBIO has more shares outstanding
  • Compared to 1 year ago, SBIO has an improved debt to assets ratio.
SBIO.CA Yearly Shares OutstandingSBIO.CA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
SBIO.CA Yearly Total Debt VS Total AssetsSBIO.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

  • SBIO has an Altman-Z score of -0.23. This is a bad value and indicates that SBIO is not financially healthy and even has some risk of bankruptcy.
  • With a decent Altman-Z score value of -0.23, SBIO is doing good in the industry, outperforming 63.64% of the companies in the same industry.
  • The Debt to FCF ratio of SBIO is 34.84, which is on the high side as it means it would take SBIO, 34.84 years of fcf income to pay off all of its debts.
  • SBIO has a Debt to FCF ratio (34.84) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 34.84
Altman-Z -0.23
ROIC/WACCN/A
WACC7.85%
SBIO.CA Yearly LT Debt VS Equity VS FCFSBIO.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 2M -2M -4M -6M -8M

2.3 Liquidity

  • A Current Ratio of 0.49 indicates that SBIO may have some problems paying its short term obligations.
  • SBIO has a Current ratio of 0.49. This is amonst the worse of the industry: SBIO underperforms 81.82% of its industry peers.
  • A Quick Ratio of 0.49 indicates that SBIO may have some problems paying its short term obligations.
  • SBIO's Quick ratio of 0.49 is on the low side compared to the rest of the industry. SBIO is outperformed by 81.82% of its industry peers.
Industry RankSector Rank
Current Ratio 0.49
Quick Ratio 0.49
SBIO.CA Yearly Current Assets VS Current LiabilitesSBIO.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. SBIO.CA Growth Analysis

3.1 Past

  • The earnings per share for SBIO have decreased strongly by -2291.67% in the last year.
  • SBIO shows a small growth in Revenue. In the last year, the Revenue has grown by 6.32%.
  • The Revenue has been growing by 26.99% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-2291.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-333.33%
Revenue 1Y (TTM)6.32%
Revenue growth 3Y26.99%
Revenue growth 5YN/A
Sales Q2Q%-48.87%

3.2 Future

  • The Earnings Per Share is expected to grow by 82.32% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 8.06% on average over the next years. This is quite good.
EPS Next Y-1615%
EPS Next 2Y23.09%
EPS Next 3Y82.32%
EPS Next 5YN/A
Revenue Next Year-16.13%
Revenue Next 2Y11.22%
Revenue Next 3Y8.06%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SBIO.CA Yearly Revenue VS EstimatesSBIO.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
SBIO.CA Yearly EPS VS EstimatesSBIO.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.05 -0.05 -0.1 -0.15

More info and screens

Find the best growth stocksShow best growing peers

4

4. SBIO.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • SBIO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • A Price/Forward Earnings ratio of 11.06 indicates a reasonable valuation of SBIO.
  • 81.82% of the companies in the same industry are more expensive than SBIO, based on the Price/Forward Earnings ratio.
  • SBIO is valuated cheaply when we compare the Price/Forward Earnings ratio to 37.95, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 11.06
SBIO.CA Price Earnings VS Forward Price EarningsSBIO.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

  • The rest of the industry has a similar Price/Free Cash Flow ratio as SBIO.
Industry RankSector Rank
P/FCF 31.4
EV/EBITDA N/A
SBIO.CA Per share dataSBIO.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

  • SBIO's earnings are expected to grow with 82.32% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y23.09%
EPS Next 3Y82.32%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. SBIO.CA Dividend Analysis

5.1 Amount

  • No dividends for SBIO!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SBIO.CA Fundamentals: All Metrics, Ratios and Statistics

SABIO HOLDINGS INC

TSX-V:SBIO (4/16/2026, 7:00:00 PM)

0.23

+0.01 (+2.22%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)03-04
Earnings (Next)05-18
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners48.36%
Ins Owner ChangeN/A
Market Cap11.73M
Revenue(TTM)46.75M
Net Income(TTM)-5.82M
Analysts85.71
Price Target0.79 (243.48%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-652.47%
Min EPS beat(2)-1286.14%
Max EPS beat(2)-18.81%
EPS beat(4)1
Avg EPS beat(4)-332.84%
Min EPS beat(4)-1286.14%
Max EPS beat(4)32.01%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-11.8%
Min Revenue beat(2)-30%
Max Revenue beat(2)6.41%
Revenue beat(4)3
Avg Revenue beat(4)-4.44%
Min Revenue beat(4)-30%
Max Revenue beat(4)6.41%
Revenue beat(8)5
Avg Revenue beat(8)-3.77%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-8.82%
PT rev (3m)-8.82%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 11.06
P/S 0.18
P/FCF 31.4
P/OCF 22.95
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.14
EYN/A
EPS(NY)0.02
Fwd EY9.04%
FCF(TTM)0.01
FCFY3.19%
OCF(TTM)0.01
OCFY4.36%
SpS1.26
BVpS-0.2
TBVpS-0.28
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -37.62%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 60.91%
FCFM 0.58%
ROA(3y)-9.32%
ROA(5y)-8.06%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y45.05%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.9%
GM growth 5YN/A
F-Score3
Asset Turnover3.02
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 34.84
Debt/EBITDA N/A
Cap/Depr 11.98%
Cap/Sales 0.21%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.49
Quick Ratio 0.49
Altman-Z -0.23
F-Score3
WACC7.85%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2291.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-333.33%
EPS Next Y-1615%
EPS Next 2Y23.09%
EPS Next 3Y82.32%
EPS Next 5YN/A
Revenue 1Y (TTM)6.32%
Revenue growth 3Y26.99%
Revenue growth 5YN/A
Sales Q2Q%-48.87%
Revenue Next Year-16.13%
Revenue Next 2Y11.22%
Revenue Next 3Y8.06%
Revenue Next 5YN/A
EBIT growth 1Y-409.52%
EBIT growth 3Y84.2%
EBIT growth 5YN/A
EBIT Next Year-351.86%
EBIT Next 3Y36.15%
EBIT Next 5YN/A
FCF growth 1Y106.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y108.82%
OCF growth 3YN/A
OCF growth 5YN/A

SABIO HOLDINGS INC / SBIO.CA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for SABIO HOLDINGS INC?

ChartMill assigns a fundamental rating of 3 / 10 to SBIO.CA.


What is the valuation status of SABIO HOLDINGS INC (SBIO.CA) stock?

ChartMill assigns a valuation rating of 4 / 10 to SABIO HOLDINGS INC (SBIO.CA). This can be considered as Fairly Valued.


What is the profitability of SBIO stock?

SABIO HOLDINGS INC (SBIO.CA) has a profitability rating of 2 / 10.